UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Transfeminine Gender Confirmation Surgery with Penile Inversion Vaginoplasty: An Initial Experience

Plastic and reconstructive surgery. Global open, 2020-05, Vol.8 (5), p.e2873-e2873

2020

Volltextzugriff (PDF)

Gaps in Training: Misunderstandings of Airway Management in Medical Students and Internal Medicine Residents

Otolaryngology-head and neck surgery, 2021-05, Vol.164 (5), p.938-943

2021

Volltextzugriff (PDF)

Sentinel lymph node biopsy for management of the N0 neck in oral cavity squamous cell carcinoma

Journal of surgical oncology, 2019-08, Vol.120 (2), p.101-108

2019

Volltextzugriff (PDF)

Presurgical induction chemotherapy for squamous cell carcinoma of the tonsil

The Laryngoscope, 2020-05, Vol.130 (5), p.1206-1211

2020

Volltextzugriff (PDF)

UEV 1. Long-term Complications of Central Venous Access Catheters: A Meta-analysis

Journal of vascular surgery, 2019-11, Vol.70 (5), p.e168-e168

2019

Volltextzugriff (PDF)

First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial

Haematologica (Roma), 2022-09, Vol.107 (9), p.2108-2120

2022

Volltextzugriff (PDF)

Race-based reporting and participation of Black individuals in registered pain clinical trials, United States, 2000 to 2019

Pain (Amsterdam), 2023-09, Vol.164 (9), p.1976-1984

2023

Volltextzugriff (PDF)

Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer

Cancer discovery, 2018-02, Vol.8 (2), p.164-173

2018

Volltextzugriff (PDF)

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial

The lancet oncology, 2019-01, Vol.20 (1), p.43-56

2019

Volltextzugriff (PDF)

5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia in a Randomized, Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen

Journal of clinical oncology, 2009-11, Vol.27 (31), p.5208-5212

2009

Volltextzugriff (PDF)

Randomized Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen Sodium (Bcl-2 antisense) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2007-03, Vol.25 (9), p.1114-1120

2007

Volltextzugriff (PDF)

Presurgical chemotherapy for HPV positive oropharyngeal squamous cancers

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18022-e18022

2022

Volltextzugriff (PDF)

Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1756-1765

2010

Volltextzugriff (PDF)

ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer

Clinical cancer research, 2021-03, Vol.27 (6), p.1663-1670

2021

Volltextzugriff (PDF)

Severe COVID-19 outcomes among patients with autoimmune rheumatic diseases or transplantation: a population-based matched cohort study

BMJ open, 2022-08, Vol.12 (8), p.e062404

2022

Volltextzugriff (PDF)

Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials

Clinical cancer research, 2024-03, Vol.30 (6), p.1121-1130

2024

Volltextzugriff (PDF)

Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial

Clinical cancer research, 2021-01, Vol.27 (1), p.52-59

2021

Volltextzugriff (PDF)

Does serial circulating tumor DNA (ctDNA) monitoring identify additional acquired actionable alterations in metastatic colorectal cancer (mCRC)?

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3540-3540

2023

Volltextzugriff (PDF)

Clinical and Functional Characterization of Atypical KRAS / NRAS Mutations in Metastatic Colorectal Cancer

Clinical cancer research, 2021-08, Vol.27 (16), p.4587-4598

2021

Volltextzugriff (PDF)

Degrading windward patch reefs and processes influencing composition, mineralogy, and stable-isotope record of peri-reefal sediment, San Salvador Island, Bahamas

Facies, 2019-10, Vol.65 (4), p.1-20, Article 39

2019

Volltextzugriff (PDF)

Anxiety, depression, and suicidal ideation among early adolescents during the COVID‐19 pandemic

Journal of adolescence (London, England.), 2024-08, Vol.96 (6), p.1379-1387

2024

Volltextzugriff (PDF)

Medical Oncologists’ Perspectives on How the Results of the IDEA Collaboration Impact the Adjuvant Treatment of Stage III Colon Cancer

The oncologist (Dayton, Ohio), 2020-03, Vol.25 (3), p.229-234

2020

Volltextzugriff (PDF)

Reply to Torlakovic, E.; Normanno, N. Comment on “Bisson et al. Novel Approach to Proficiency Testing Highlights Key Practice Variations in Cancer Biomarker Delivery. J. Mol. Pathol. 2024, 5, 1–10”

Journal of Molecular Pathology, 2024-09, Vol.5 (3), p.262-263

2024

Volltextzugriff (PDF)

Novel Approach to Proficiency Testing Highlights Key Practice Variations in Cancer Biomarker Delivery

Journal of Molecular Pathology, 2024-01, Vol.5 (1), p.1-10

2024

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(53)
Science & Technology
(53)
Humans
(42)
Female
(27)
Male
(22)
Middle Aged
(22)
Aged
(19)
Oncology
(19)
Adult
(16)
Aged, 80 And Over
(12)
Surgery
(12)
Treatment Outcome
(11)
Biological And Medical Sciences
(10)
Cancer
(10)
Medical Sciences
(10)
Hematology
(9)
Retrospective Studies
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Follow-Up Studies
(7)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Transfeminine Gender Confirmation Surgery with Penile Inversion Vaginoplasty: An Initial Experience

Gaps in Training: Misunderstandings of Airway Management in Medical Students and Internal Medicine Residents

Sentinel lymph node biopsy for management of the N0 neck in oral cavity squamous cell carcinoma

Presurgical induction chemotherapy for squamous cell carcinoma of the tonsil

UEV 1. Long-term Complications of Central Venous Access Catheters: A Meta-analysis

First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial

Race-based reporting and participation of Black individuals in registered pain clinical trials, United States, 2000 to 2019

Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer

Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 Study

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial

5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia in a Randomized, Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen

Randomized Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen Sodium (Bcl-2 antisense) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Presurgical chemotherapy for HPV positive oropharyngeal squamous cancers

Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia

ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer

Severe COVID-19 outcomes among patients with autoimmune rheumatic diseases or transplantation: a population-based matched cohort study

Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials

Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial

Does serial circulating tumor DNA (ctDNA) monitoring identify additional acquired actionable alterations in metastatic colorectal cancer (mCRC)?

Clinical and Functional Characterization of Atypical KRAS / NRAS Mutations in Metastatic Colorectal Cancer

Degrading windward patch reefs and processes influencing composition, mineralogy, and stable-isotope record of peri-reefal sediment, San Salvador Island, Bahamas

Anxiety, depression, and suicidal ideation among early adolescents during the COVID‐19 pandemic

Medical Oncologists’ Perspectives on How the Results of the IDEA Collaboration Impact the Adjuvant Treatment of Stage III Colon Cancer

Reply to Torlakovic, E.; Normanno, N. Comment on “Bisson et al. Novel Approach to Proficiency Testing Highlights Key Practice Variations in Cancer Biomarker Delivery. J. Mol. Pathol. 2024, 5, 1–10”

Novel Approach to Proficiency Testing Highlights Key Practice Variations in Cancer Biomarker Delivery

Suchergebnisse filtern